Transfer-pricing adjustments under TNMM remain confined to associated-enterprise international transactions, while exceptional COVID-19 overheads require separate operating-margin treatment.
COVID-19-related unabsorbed fixed overheads that are exceptional, identifiable and non-recurring should be excluded from operating costs when computing the tested party's operating margin, where they materially impair comparability. Capacity-underutilisation adjustment requires comparable-company data and may be determined afresh using statutory information-gathering powers, with an opportunity for the assessee to respond. Under TNMM, transfer-pricing adjustment is confined to international transactions with associated enterprises and cannot extend to unrelated-party dealings. Bad-debt treatment requires verification to prevent double addition. Working-capital adjustment requires evidence of material differences between the tested party and comparables and their effect on price, cost or profit.
Issues: (i) Whether COVID-19-related unabsorbed fixed overheads should be excluded as extraordinary costs in computing the tested party's operating margin; (ii) Whether capacity-underutilisation adjustment should be considered for transfer-pricing comparability; (iii) Whether the transfer-pricing adjustment under TNMM can extend to non-associated-enterprise transactions; (iv) Whether the bad-debt addition resulted in double addition; (v) Whether working-capital adjustment should be granted in determining the arm's length price.
Issue (i): Whether COVID-19-related unabsorbed fixed overheads should be excluded as extraordinary costs in computing the tested party's operating margin.
Analysis: The manufacturing operations and sales were materially affected by lockdown conditions, while substantial salary, depreciation and fixed overheads continued to be incurred. Such costs did not generate operating revenue and were incurred to preserve employment and business continuity rather than in ordinary operations. Exceptional, clearly identifiable and non-recurring COVID-19 costs materially affecting comparability warrant separate treatment under the transfer-pricing comparability framework.
Conclusion: COVID-19-related extraordinary fixed overheads shall be excluded from operating cost while computing the operating margin. This issue is in favour of the assessee.
Issue (ii): Whether capacity-underutilisation adjustment should be considered for transfer-pricing comparability.
Analysis: The record established underutilisation of the assessee's installed capacity. The absence of publicly available capacity-utilisation data of comparable companies could not require the assessee to perform an impossible task. Relevant information from comparable companies may be obtained through the statutory information-gathering power, with opportunity to the assessee before determination of the adjustment.
Conclusion: The capacity-underutilisation claim is remitted for obtaining comparable-company data and fresh determination of the appropriate adjustment. This issue is partly in favour of the assessee.
Issue (iii): Whether the transfer-pricing adjustment under TNMM can extend to non-associated-enterprise transactions.
Analysis: The transfer-pricing regime authorises redetermination only of income arising from international transactions. Transactions with independent parties are presumed to be at arm's length, and extending the adjustment to them would alter profits from non-associated-enterprise dealings beyond the scope of the regime.
Conclusion: The adjustment shall be restricted to international transactions with associated enterprises and shall not be applied to transactions with unrelated parties. This issue is in favour of the assessee.
Issue (iv): Whether the bad-debt addition resulted in double addition.
Analysis: The claim was that the amount added through processing had already been offered to tax in the return. The objection was not examined on merits, requiring verification of the return computation and the claimed deduction.
Conclusion: The bad-debt claim is remitted for verification and decision on merits in accordance with law. This issue is partly in favour of the assessee.
Issue (v): Whether working-capital adjustment should be granted in determining the arm's length price.
Analysis: A working-capital adjustment requires material differences between the tested party and comparables, and their impact on price, cost or profit, to be demonstrated with supporting data. The record did not establish those differences sufficiently, but the assessee is to be given an opportunity to furnish the requisite material.
Conclusion: The working-capital adjustment claim is remitted for fresh consideration upon demonstration of material differences. This issue is partly in favour of the assessee.
Final Conclusion: The operating-margin computation must exclude the identified extraordinary COVID-19 costs, and the transfer-pricing adjustment is confined to associated-enterprise international transactions; the remaining adjustment claims require fresh verification or determination.
Ratio Decidendi: Transfer-pricing adjustment under the arm's-length regime may be made only in respect of international transactions with associated enterprises and cannot be extended to unrelated-party transactions.